Medical News

RSS

Cantwell amendment will raise cost of prescription drugs: PCMA

“America’s pharmacy benefit managers (PBMs) believe strongly in the principle of transparency and empowering payers to make informed health-care purchasing decisions resulting in lower prescription drug costs and higher quality. Regrettably, today’s amendment moves the health care system in the opposite direction.”

26 Sep 2009

AETNA's nutrition program to counter childhood obesity

Aetna Better Health, formerly Aetna Medicaid and CHIP Services, today announced an eight-week nutrition and exercise program for children at the North Fort Worth Branch of the Boys and Girls Clubs of Greater Fort Worth. The pilot program, named ACTIVATE Kids, was created to educate children on the risks of childhood obesity.

26 Sep 2009

Biden emerges as health care messenger

The vice president took the stage Wednesday for the administration's health reform campaign with a talk with seniors at Leisure World in suburban Maryland. The Associated Press reports: "Vice President Joe Biden sought to reassure nervous seniors Wednesday that they won't see cuts in their Medicare benefits if the nation's health care system is revamped. ...

26 Sep 2009

CAPT organizes events to draw attention to budget cuts and layoffs

WHY: The California Association of Psychiatric Technicians is continuing a series of weekly informational pickets at state hospitals, developmental centers and prisons, this time at three locations: Coalinga State Hospital, Lanterman Developmental Center and Metropolitan State Hospital. The events will draw attention to ongoing state budget cuts that are not only hurting employees, but also the vital services Psych Techs provide to Californians in their care.

26 Sep 2009

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.

26 Sep 2009

NIEHS director to discuss health concerns with citizens

The director of the National Institute of Environmental Health Sciences (NIEHS) will visit Milwaukee to preside over a "Town Hall Meeting" in which the public can discuss with local, state and federal authorities how the physical environment underlies many of the health problems in Milwaukee.

26 Sep 2009

G20 to focus on global poverty

The move to make the G20 the world's leading economic body holds potential for broader coordination in the global fight against poverty and hunger, though it may also pose risks for achieving promises made by G8 leaders at previous summits, say aid policy experts at World Vision.

26 Sep 2009

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

26 Sep 2009

Millennium Foundation announces fundraising initiative for global health

The Millennium Foundation for Innovative Finance for Health today announced MASSIVEGOOD, a new, innovative travel-related fundraising initiative that will help finance health care for the world's poor.

26 Sep 2009

Behavioral hospital receives Champion in Health Care award

Eating Recovery Center (www.eatingrecoverycenter.com), the only behavioral hospital in Colorado focused on comprehensive and sustainable treatment of eating disorders, was honored as a "Champion in Health Care" by the Denver Business Journal at the newspaper's annual awards ceremony last night.

26 Sep 2009

Meta Health Services to raise $250,000 for general working capital

Meta Health Services Inc. (TSX-V: MHS.H) is pleased to announce that, subject to regulatory and shareholder approval, it will conduct a non-brokered private placement of up to 50,000,000 units at a price of $0.005 per unit, for gross proceeds of up to $250,000.

26 Sep 2009

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.

26 Sep 2009

Psychoeducational program for wellbeing

At the World Congress on Psychosomatic Medicine in Torino, Italy, the state of the science of happiness has been discussed.

26 Sep 2009

NSF funds UAB to purchase highly-specialized imaging system

The National Science Foundation has awarded $431,200 to the University of Alabama at Birmingham (UAB) Department of Physics to facilitate the purchase of a new highly-specialized imaging system - the first of its kind in Alabama - that will be a centerpiece of a new interdisciplinary research laboratory on campus.

26 Sep 2009

European CHMP recommends marketing approval for Sanofi-aventis' Multaq

Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).

26 Sep 2009

NIH grants $5 million to Pittsburgh researchers

Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs.

26 Sep 2009

EMS provides free resources for protection against swine flu

Emergency Management & Safety Solutions (EMS), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help people prepare for, prevent transmission of and take care of the ill to survive this wave of this year’s H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and at least 3,486 people have died – including 1,000 Americans.

26 Sep 2009

Teva to market generic version of AstraZeneca's antipsychotic agent Seroquel tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 1, 2008 decision by the District Court to grant AstraZeneca’s motion for summary judgment of no inequitable conduct related to U.S. Patent No. 4,879,288.

26 Sep 2009

GenVec to receive $2.3M from NIAID for HIV vaccine candidate production

GenVec, Inc. announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its third option period (year four) under a previously announced, five-year contract with GenVec valued at up to $52 million for the production of HIV vaccines.

26 Sep 2009

Personal approach to psychological well-being

At the World Congress on Psychosomatic Medicine in Torino, Italy, Carol Ryff, Professor of Psychology at the University of Wisconsin, has described how, more than simply feeling happy, it is the personal approach to psychological well-being that matters.

26 Sep 2009